Previous close | 0.8776 |
Open | 0.8799 |
Bid | 0.9943 x 200 |
Ask | 1.0200 x 1000 |
Day's range | 0.8799 - 1.0100 |
52-week range | 0.8000 - 2.1000 |
Volume | |
Avg. volume | 1,096,570 |
Market cap | 114.169M |
Beta (5Y monthly) | -0.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies OptiNose's stock price is sensitive to their trading...
Gain Therapeutics (GANX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OptiNose (OPTN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.